Sort
82,697 grants matching “vaccine development”
ERIN CRC: Molecular Basis of Nontyphoidal Salmonella Emergence
$1,142,379Samuel I. Miller · University Of Washington · U19 · FY2014 · AI
Novel Therapeutic Strategies Targeting Re-emerging Alphaviruses
$1,142,044Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2017 · AI
Refinement of DNA-Launched NanoParticles decorated with Apex and CD4bs B cell lineage targeting Envs (DLNP-ACEs)
$1,141,993Daniel Kulp · Wistar Institute · U19 · FY2024 · AI
Conditionally replicating Mycobacterium tuberculosis vaccines
$1,141,865Sabine Ehrt · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · AI
Predicting immune responses that correlate with protection against tuberculosis
$1,141,651Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · HL
Project 2. Animal studies to elucidate the optimal sequence of Env immunogens for induction of distal MPER bnAbs
$1,141,610S Munir Alam · Duke University · P01 · FY2020 · AI
Maternal and infant immunization to eliminate breast milk transmission of HIV-1
$1,141,522Sallie R. Permar · Duke University · P01 · FY2016 · AI
CIVIC SARS-CoV-2 Research Activities
$1,141,458Tony Moody · Duke University · N01 · FY2021 · AI
Dendritic cells heterogeneity and function
$1,141,362Roxane Tussiwand · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE
Small-molecule inhibitors of flavivirus entry
$1,141,241Priscilla Li-Ning Yang · Harvard Medical School · U19 · FY2014 · AI
Molecular Biology Of Retroviruses Associated With AIDS
$1,141,124Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
A Novel Systemic and Mucosal Adjuvant for Biodefense
$1,141,009Mario Barro · Global Vaccines, Inc. · U01 · FY2008 · AI
Development of MecVax, a Cross Protective Subunit Vaccine for ETEC
$1,140,647Weiping Zhang · University Of Illinois At Urbana-Champaign · R01 · FY2024 · AI
GMP MANUFACTURE OF CLINICAL GRADE THERAPEUTIC VACCINE FOR THE TREATMENT OF PATIENTS WITH CHRONIC HBV
$1,140,300Valerian Nakaar · Carogen Corporation · R44 · FY2023 · DK
Antidotes to Anthrax Lethal Factor Intoxication
$1,140,279Alan Thomas Johnson · Panthera Biopharma, Llc · U01 · FY2012 · AI
Metabolic Studies of Mouse Models of Obesity and Diabetes
$1,140,208Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2011 · DK
Consensus Gene-Based Immunogens in Rhesus Monkeys
$1,140,185Norman L Letvin · Duke University · P01 · FY2008 · AI
Sequencing Technology Core
$1,139,925Donna Muzny · Baylor College Of Medicine · U19 · FY2021 · AI
Development of a Vaccine for HIVAIDS: Cellular Immunity
$1,139,808Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Molecular Genetics Of Scrapie Pathogenesis
$1,139,579Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Advancing a Glioma Immunotherapy
$1,139,204Dwaine Franklin Emerich · In Cytu, Inc. · R44 · FY2014 · NS
Advancement to Clinical Candidate of Novel, Potent and Selective Chikungunya virus inhibitor series
$1,139,136Daniel C Pevear · Venatorx Pharmaceuticals, Inc. · R44 · FY2016 · AI
Task V18: STUDY TO EVALUATE THE EFFICACY OF TOXIN IN ANIMAL MODEL
$1,139,090Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2023 · AI
Identifying COVID-19 vaccine deserts using Machine Learning and Geospatial Analyses to target Community -engaged testing for vulnerable rural populations to prevent localized outbreaks
$1,138,915Brian Hendricks · West Virginia University · U01 · FY2023 · MD
Therapeutics that target processivity complex proteins of pox and other viruses
$1,138,476Robert Paul Ricciardi · University Of Pennsylvania · U01 · FY2009 · AI